Nasdaq GlobeNewswire

PubMatic and Ringier Partner to Drive Programmatic in the Romanian Market

Del

Ringier Becomes PubMatic's Preferred Partner in Romania as the Publisher Adopts its Header Bidding Technology

PubMatic, the publisher-focused sell-side platform (SSP) for an open digital media future, today announced a partnership with Ringier Romania, the leading publisher in the country and part of the world's largest international media company, Ringier AG, to help further develop programmatic in the Romanian market.   

The partnership sees Ringier become PubMatic's preferred partner in Romania and Ringier adopt PubMatic's OpenWrap header bidding solution to drive more effective monetisation strategies.

"We have always been a forward-looking business when it comes to adopting technologies. When assessing technologies, we look for market-leading solutions that improve how we work with our buyers, while also delivering commercial benefits to our business. Working with PubMatic will allow us to open up our inventory to more advertisers than before and diversify our revenue stream." explained Andrei Ursuleanu, Group Head of Advertising Sales, Ringier Romania.

George Stefanuca, Group Head of Data, Research and Business Intelligence, Ringier Romania added, "As owners of the leading marketplaces for jobs and real estate, we are continuously looking to use our quality first party data to deliver effective data-driven campaigns for advertisers. PubMatic will help us make these opportunities available to a wider audience."

Ringier was one of the first publishers in Romania to introduce a data management platform and is committed to implementing technologies to better serve its clients' needs.

"As the leading premium publisher in Romania, we are delighted to be working with Ringier. Eastern Europe is a developing market for PubMatic and partnering with the number one player in this country is an important step for us in this region. Brands are demanding access to safe environments, which is what Ringier delivers, and this partnership reinforces our commitment to quality," commented Bill Swanson, Chief Revenue Officer, EMEA at PubMatic.

About PubMatic

PubMatic is a publisher-focused sell-side platform for an open digital media future. Featuring leading omni-channel revenue automation technology for publishers and enterprise-grade programmatic tools for media buyers, PubMatic's publisher-first approach enables advertisers to access premium inventory at scale. Processing over ten trillion advertiser bids per month, PubMatic has created a global infrastructure to drive publisher monetization and control over their ad inventory. Since 2006, PubMatic's focus on data and technology innovation has fueled the rise of the programmatic industry as a whole. Headquartered in Redwood City, California, PubMatic operates 13 offices and six data centers worldwide.

PubMatic is a registered trademark of PubMatic, Inc. Other trademarks are the property of their respective owners.

PubMatic Contact:
Roger Williams
VP, International Marketing
roger.williams@pubmatic.com

About Ringier Romania

Founded in 1992, Ringier Romania is the biggest publishing group in Romania and a key player on the local media market. Ringier Romania is the official local representative of the largest internationally operating Swiss media company Ringier AG, renowned for producing the highest quality content for more than 180 years for the world's most influential audiences. Managing over 120 newspapers and magazines (print & digital), producing video, web, mobile platforms and attracting thousands of consumers, the company's portfolio includes some of the most iconic titles in the local media such as: Libertatea, Noizz, ELLE, Viva!, Unica, Avantaje, Glamour, Revista Psychologies, eJobs, We are HR and Imobiliare. For more information, please visit our website Ringier.ro or follow Ringier Romania on Facebook.

Ringier Romania Contact:
Marina Sarmaniuc
Marketing & PR
marina.sarmaniuc@ringier.ro

 




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: PubMatic, Inc. via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

Primal Pictures Partners with Physitrack to Create a Unique Patient Education Solution25.6.2018 18:00Pressemelding

LONDON, June 25, 2018 (GLOBE NEWSWIRE) -- Today, Primal Pictures, pioneer of the world's most medically-accurate and detailed 3D models of human anatomy, and Physitrack, the market-leading patient engagement and Telehealth solution provider, announce their partnership on a unique anatomically augmented home exercise and patient education feature. The feature inside Physitrack, which is powered by Primal Pictures, will allow healthcare practitioners to better educate their patients, and therefore help patients to improve their health outcomes. "Even the best physical therapy regime will be unsuccessful without proper patient education," explained Henrik Molin, CEO and co-founder of Physitrack. "That's why Physitrack developed what has become the industry's gold standard in patient engagement and outcome tracking. With Primal Pictures, we saw the opportunity to take our solution to a new level by helping patients make the connection between their physical therapy regime and the anatomy i

EPAM's InfoNgen(TM) Debuts With Highest Score Possible in Seven Criteria in AI-Based Text Analytics Platforms Report by Independent Research Firm25.6.2018 16:58Pressemelding

InfoNgen, categorized as one of the top eight providers that matter most, is a fully integrated, end-to-end turnkey solution that helps enterprises become more insights-driven NEWTOWN, Pa., June 25, 2018 (GLOBE NEWSWIRE) -- EPAM Systems, Inc. (NYSE:EPAM), a leading global provider of digital platform engineering and software development services, today announced that it has been named a Contender in the report "The Forrester Wave(TM): AI-Based Text Analytics Platforms, Q2 2018" for its product InfoNgen(TM). InfoNgen ranked among the highest scores in the enterprise features, RPA functionality, training data for machine learning, focus on cloud and SaaS, and overall revenue criteria. According to the report, "[EPAM's] InfoNgen text analytics product is a good example of how modern consulting firms and systems integrators differentiate - they productize solutions." "EPAM's inclusion in this report, along with leaders like IBM and SAS, demonstrates, in our opinion, our ability to extend e

Align Technology Reaches One Millionth Invisalign(R) Patient in the EMEA Region25.6.2018 16:00Pressemelding

Milestone Reflects Accelerating Adoption of Invisalign Treatment Among Adults and Teens in Europe SAN JOSE, Calif. and AMSTERDAM, The Netherlands, June 25, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq:ALGN), today announced that it shipped its one millionth Invisalign case for the EMEA region in April, 2018. This significant milestone for the company and the more than 34 thousand Invisalign-trained orthodontists and general dentists in the region reflects accelerating adoption of Invisalign clear aligner therapy in Europe, Middle East and Africa. "I am immensely proud to announce that we have reached yet another significant milestone for EMEA with our one millionth Invisalign patient in the region. The demand and adoption rate for Invisalign clear aligners in EMEA has accelerated rapidly during recent years. I would like to thank our doctors for their trust and confidence in treating patients with the Invisalign system, and acknowledge the more than one million patients in E

Novelion Therapeutics Announces Presentation of Positive Metreleptin Data at American Diabetes Association Scientific Sessions25.6.2018 14:00Pressemelding

Data Show Leptin Replacement Therapy Sustainably Decreased Weight Over Time in Patients with Low Baseline Leptin Levels Company plans to initiate Phase 2 proof of concept study in hypoleptinemic metabolic disorder (HMD) by year-end VANCOUVER, British Columbia, June 25, 2018 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing and commercializing therapies for individuals living with rare diseases, today announced that clinical data from a metreleptin study assessing weight loss in overweight and obese adults with low leptin levels will be featured in a poster presentation at the American Diabetes Association's (ADA) 78th Scientific Sessions, being held June 22-26, 2018 in Orlando. The study, titled "Efficacy of Metreleptin for Weight Loss in Overweight and Obese Adults With Low Leptin Levels," was conducted in adults with low baseline leptin, defined as <16 ng/mL in females and <5 ng/mL in males, and Body Mass Index (BMI) lev

ERYTECH Confirms Strategic Focus of Eryaspase on Solid Tumors and Ceases Development in Acute Lymphoblastic Leukemia25.6.2018 00:06Pressemelding

Conference call on Monday, June 25th at 2:30 pm CET/8:30 am EDT Focuses development efforts on solid tumor indications Confirms planned launch of company-sponsored randomized Phase 2 trial in first-line pancreatic cancer, in addition to ongoing launch of Phase 3 trial in second-line pancreatic cancer. Expands eryaspase production capacity in the United States and France Plans to cease development in acute lymphoblastic leukemia (ALL), including withdrawal of European Marketing Authorization Application (MAA) LYON, France and CAMBRIDGE Mass., June 24, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext:ERYP) (Nasdaq:ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will focus its development efforts for its product candidate eryaspase on the potential treatment of selected solid tumor indications. The company also announced that it plans to cease its development pro

CORRECTING and REPLACING -- PRESS ALERT & INVITATION: Arbitrade to Hold a Press Conference on June 28th From Bermuda - Its New Global Headquarters23.6.2018 14:00Pressemelding

NEW YORK, June 23, 2018 (GLOBE NEWSWIRE) -- In a press release issued under the same headline earlier today by Arbitrade, please note that the correct date of the event is Thursday, June 28, 2018 at 8:00 a.m. EDT. The corrected release follows: This is an invitation to all media following Arbitrade and/or covering the cryptocurrency markets. You are invited to join Arbitrade's Chairman, Len Schutzman, and management who will discuss their progress toward establishing Arbitrade as a world-class cryptocurrency exchange and coin company. They will also discuss their move and incorporation into Bermuda, one of the world's best regulated jurisdictions and a platform from which Arbitrade will reach out to several international markets. It will be a lively discussion that will also include details of the many economic and social advantages and new jobs that companies, like Arbitrade, will bring to countries in which they settle and do business around the world. Details of how to access the pr

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom